Skip to main content Advertisement Menu Search Search Publisher main menu Journals Submissions Publishing services About My Account Follow BioMed Central Twitter Facebook Arthritis Research & Therapy Arthritis Research & Therapy main menu Home About Articles Articles Recent Most accessed Recent articles Recent articles RSS 1. Letter Response to: ‘A dose–response relationship between severity of disc degeneration and intervertebral disc height in the lumbosacral spine’ Kaj S. Emanuel, Idsart Kingma, Marco N. Helder and Theodoor H. Smit Published on: 8 February 2016 2. Editorial The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? Mirko Manetti, Serena Guiducci and Marco Matucci-Cerinic Published on: 5 February 2016 3. Research article Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission Stefano Alivernini, Giusy Peluso, Anna Laura Fedele, Barbara Tolusso, Elisa Gremese and Gianfranco Ferraccioli Published on: 3 February 2016 4. Research article Changes in resting state functional connectivity after repetitive transcranial direct current stimulation applied to motor cortex in fibromyalgia patients Chelsea M. Cummiford, Thiago D. Nascimento, Bradley R. Foerster, Daniel J. Clauw, Jon-Kar Zubieta, Richard E. Harris and Alexandre F. DaSilva Published on: 3 February 2016 5. Research article Evaluation of treatments for sacroiliitis in spondyloarthropathy using the Spondyloarthritis Research Consortium Canada scoring system Yang Cui, Jinping Zheng, Xiao Zhang, Hui Zeng and Riqiang Luo Published on: 1 February 2016 View all articles Most accessed articles Most accessed articles RSS 1. Review Use of NSAIDs in treating patients with arthritis Leslie J Crofford Published on: 24 July 2013 2. Research article Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis Michel PM Vierboom, Elia Breedveld, Ivanela Kondova and Bert A 't Hart Published on: 26 October 2010 3. Research article Remission in psoriatic arthritis: is it possible and how can it be predicted? Tajvur P Saber, CT Ng, Guillaume Renard, Bernadette M Lynch, Eliza Pontifex, Ceara AE Walsh, Alexia Grier, Marian Molloy, Barry Bresnihan, Oliver FitzGerald, Ursula Fearon and Douglas J Veale Published on: 18 May 2010 4. Review Microbes, the gut and ankylosing spondylitis Mary-Ellen Costello, Dirk Elewaut, Tony J Kenna and Matthew A Brown Published on: 6 June 2013 5. Research article Cartilage oligomeric matrix protein specific antibodies are pathogenic Hui Geng, Kutty Selva Nandakumar, Anna Pramhed, Anders Aspberg, Ragnar Mattsson and Rikard Holmdahl Published on: 20 August 2012 View all articles Article collections Measuring meaningful change in lupus clinical trials Biology and clinical applications of stem cells for autoimmune and musculoskeletal disorders At the interface between immunology and neurology in rheumatic diseases View all collections Editors-in-Chief Professor Christopher Buckley, University of Birmingham, UK Professor Harris Perlman, Northwestern University, USA Aims and scope Arthritis Research & Therapy is an international, peer-reviewed online journal, publishing original research, reviews, commentaries and reports. The major focus of the journal is on cellular and molecular mechanisms of arthritis, musculoskeletal conditions and systemic autoimmune rheumatic diseases and translation of this knowledge into advances in clinical care. Original basic, translational laboratory and clinical research is considered for publication along with results of early and late phase therapeutic trials. Review series: New technologies Written by renowned experts in the field, this collection of open access Review articles explores the use of RNA sequencing, cytometry, metabolomics and next-generation DNA sequencing in rheumatic disease. Reflections of a rheumatologist Rheumatoid vasculitis: going, going, but not yet gone Read more from David Pisetsky Featured review: Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity “Since 2002, one new agent has been approved by the US Food and Drug Administration for systemic lupus erythematosus (SLE). Experiences from the field conducting trials of all the agents tested during this period have provided valuable practical insights. These insights harnessed with basic methodological work on the minimal clinically important difference (MCID) should improve the efficiency and the clinical relevance of future trials.” This review, by Choi et al., provides an update on methods to determine a clinically meaningful difference when conducting trials of new agents for SLE. Submit a manuscript Impact Factor: 3.75 Submission Guidelines Editorial Board Sign up to article alerts Follow Follow us on Twitter ISSN: 1478-6362 Advertisement Contact us Jobs Manage manuscripts Sign up for article alerts Manage article alerts Leave feedback Press center Read more on our blogs Policies Licensing Terms and conditions Privacy statement Accessibility Cookies Follow BioMed Central Twitter Facebook Google Plus YouTube LinkedIn Reddit Weibo © 2016 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and Cookies policy.